CYTOKINE REGULATION OF CORTICOSTEROID RECEPTORS IN THE RAT HIPPOCAMPUS - EFFECTS OF INTERLEUKIN-1, INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR ANDLIPOPOLYSACCHARIDE
C. Betancur et al., CYTOKINE REGULATION OF CORTICOSTEROID RECEPTORS IN THE RAT HIPPOCAMPUS - EFFECTS OF INTERLEUKIN-1, INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR ANDLIPOPOLYSACCHARIDE, Neuroendocrinology, 62(1), 1995, pp. 47-54
The effects of interleukin-1 beta(IL-1), interleukin-6(IL-6), tumor ne
crosis factor alpha(TNF) and lipopolysaccharide (LPS) on hippocampal c
orticosteroid receptors were studied in the rat. Type I (mineralocorti
coid) and type II (glucocorticoid) receptors were measured in hippocam
pal cytosolic fractions with the radioligand binding technique, using
H-3-corticosterone and H-3-RU 28362, respectively. LPS, administered i
ntraperitoneally (50 mu g/kg 8 h before sacrifice or 100 mu g/kg injec
ted twice, 16 and 8 h before sacrifice) to rats which had been previou
sly adrenalectomized to allow for clearance of endogenous corticostero
ne, did not modify either type of corticosteroid receptors in the hipp
ocampus. IL-1, IL-6, TNF or saline were injected intracerebroventricul
arly (50 ng/rat) and the animals were killed 3 h after. Type I recepto
rs were not affected by any of the cytokines studied. Moreover, no cha
nges in type II receptors were observed after IL-1 or IL-6 administrat
ion. In contrast, hippocampal type II receptors were dramatically decr
eased after the injection of TNF. The TNF-induced downregulation of ty
pe II receptors was secondary to a marked decrease in the affinity of
the receptors (K-d increased 7.2-fold), accompanied by a 51% decrease
in receptor number (B-max). These results emphasize the important role
played by TNF in the modulation of the hypothalamic-pituitary-adrenal
axis during immune/inflammatory processes and extend the central site
s of action of the cytokine to the corticosteroid receptors of the hip
pocampus.